The risk of transmission of hepatitis B from HBsAg(-), HBcAb(+), HBIgM(-) organ donors.
about
Molecular Mechanisms to Control Post-Transplantation Hepatitis B RecurrenceEvolution of hepatitis B management in kidney transplantationKidney Transplantation From Donors with Hepatitis BAntibodies to hepatitis B surface antigen prevent viral reactivation in recipients of liver grafts from anti-HBC positive donorsAsian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.Reactivation of hepatitis B with reappearance of hepatitis B surface antigen after chemotherapy and immunosuppression.Persistence of infectious hepadnavirus in the offspring of woodchuck mothers recovered from viral hepatitis.Prevention of de novo HBV infection by the presence of anti-HBs in transplanted patients receiving core antibody-positive livers.Covalently closed circular DNA is the predominant form of duck hepatitis B virus DNA that persists following transient infection.Donor race does not predict graft failure after liver transplantationContradictory immune response in post liver transplantation hepatitis B and C.Long-term efficacy of nucleoside monotherapy in preventing HBV infection in HBsAg-negative recipients of anti-HBc-positive donor livers.An unusual cause of elevated values on liver function tests in a liver transplant patient.Prophylaxis against de novo hepatitis B for liver transplantation utilizing hep B core (+) donors: does hepatitis B immunoglobulin provide a survival advantage?Viral hepatitis B: clinical and epidemiological characteristics.Current use of hepatitis B immune globulin for prevention of de novo hepatitis B in recipients receiving anti-HBc-positive livers.Adult Living Donor Liver Transplantation Using Hepatitis B Core Antibody-Positive Grafts in Korea, a Hepatitis B-endemic Region.Post-transfusion occult hepatitis B (OBI): a global challenge for blood recipients and health authoritiesLow prevalence of HBV DNA in the liver allograft from anti-HBc-positive donors: a single-center experience.Prophylaxis of hepatitis B infection in solid organ transplant recipients.PHS guideline for reducing human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission through organ transplantationHepatitis B Virus Reactivation in the Setting of Cancer Chemotherapy and Other Immunosuppressive Drug Therapy.Viral infection after renal transplantation: surveillance and management.Long-lasting memory T cell responses following self-limited acute hepatitis BOutcomes Among Children Who Received a Kidney Transplant in the United States From a Hepatitis B Core Antibody-Positive Donor, 1995-2010.Hepatitis B in renal transplant patients.Unsolved problems and future perspectives of hepatitis B virus vaccination.Positive suggestions about the anti-HBc positive donor.Update on Prevention, Diagnosis, and Treatment and of Chronic Hepatitis B: AASLD 2018 Hepatitis B Guidance.
P2860
Q26799246-54A9237A-19AA-4784-A5DF-1C252A14C8DDQ26995706-5D82BB8C-74B2-4BD1-A58A-97C6B41C3B16Q28079212-C127756C-0631-45AA-BF67-0451AF30643AQ28344359-6D58D995-7BDD-4522-A9A5-427FF3A48B20Q30391932-46262226-C074-43A5-A608-BA0845D6475EQ30434625-C0C7A710-2E66-401F-91D2-68D6E7AB1AC7Q33855141-443D81A4-6381-47C7-BA42-321DB3F7CF0CQ33867301-90442588-C10A-4609-904A-F7E4E21FFF88Q33984190-32CA2944-D444-4970-88DF-B971BAF6735FQ34007521-90DB00F3-F238-4364-88DF-DAF994201F09Q34152074-6465FEA5-2A19-4489-B48B-E0F0E49688C3Q34365421-477EAB9D-74CF-4F51-A99A-D7A69144D322Q34555551-95D846B2-0811-4C47-85FA-50F51B5239BDQ34917705-C3F0D5C0-7684-48D5-924A-7A4E3B6BBC77Q34930389-24876F68-DAE5-41A6-9D70-A1F5F5435600Q34959703-251803F7-82B5-447B-8078-D99FB866D6C5Q35195474-DF135C3C-2418-4114-AD5B-826149602083Q35603758-84ECD157-9832-41C5-9857-7BA54BE9FEA4Q36344884-DF25E8B1-35C8-43C9-8DA4-22A0301B5E13Q36886518-23C7DEFC-CCBD-4FFF-A416-CE9F22FBD6E7Q36909187-57CA008D-0557-4D51-91AF-4825BD815B8FQ36958944-5C8A0856-373A-4221-9F0A-DAF2975EC4AAQ37097708-215DB784-82EF-4E1B-BD7E-5E761468E63AQ37359318-337F3A93-9569-4692-A1F7-B8E1CCCF9A3DQ40937256-A7F90D3B-4562-4494-9BF0-6D7A4E58D249Q41690591-A970A7A9-459D-4AF0-BC7D-55C332FBE229Q42412334-C11C97AF-5DAD-4D12-A002-3D6E72890CF7Q43006521-8430CB96-0A3E-4F00-B77F-A6599E615A6CQ50190669-BDC2690E-0670-446E-822C-10274904D41E
P2860
The risk of transmission of hepatitis B from HBsAg(-), HBcAb(+), HBIgM(-) organ donors.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
The risk of transmission of hepatitis B from HBsAg(-), HBcAb(+), HBIgM(-) organ donors.
@en
type
label
The risk of transmission of hepatitis B from HBsAg(-), HBcAb(+), HBIgM(-) organ donors.
@en
prefLabel
The risk of transmission of hepatitis B from HBsAg(-), HBcAb(+), HBIgM(-) organ donors.
@en
P2093
P1433
P1476
The risk of transmission of hepatitis B from HBsAg(-), HBcAb(+), HBIgM(-) organ donors
@en
P2093
Roberts JP
Tomlanovich SJ
Vincenti F
P304
P50
P577
1995-01-01T00:00:00Z